154 related articles for article (PubMed ID: 2019419)
1. FUT-175 as a potent inhibitor of C5/C3 convertase activity for production of C5a and C3a.
Inagi R; Miyata T; Maeda K; Sugiyama S; Miyama A; Nakashima I
Immunol Lett; 1991 Jan; 27(1):49-52. PubMed ID: 2019419
[TBL] [Abstract][Full Text] [Related]
2. Methionine modification impairs the C5-cleavage function of cobra venom factor-dependent C3/C5 convertase.
Fu Q; McPhie P; Gowda DC
Biochem Mol Biol Int; 1998 Jun; 45(1):133-44. PubMed ID: 9635137
[TBL] [Abstract][Full Text] [Related]
3. Hybrid proteins of Cobra Venom Factor and cobra C3: tools to identify functionally important regions in Cobra Venom Factor.
Hew BE; Wehrhahn D; Fritzinger DC; Vogel CW
Toxicon; 2012 Sep; 60(4):632-47. PubMed ID: 22609532
[TBL] [Abstract][Full Text] [Related]
4. The effect of FUT-175 (Nafamstat Mesilate) on C3a, C4a and C5a generation in vitro and inflammatory reactions in vivo.
Issekutz AC; Roland DM; Patrick RA
Int J Immunopharmacol; 1990; 12(1):1-9. PubMed ID: 2303313
[TBL] [Abstract][Full Text] [Related]
5. Identification of intermolecular bonds between human factor B and Cobra Venom Factor important for C3 convertase stability.
Hew BE; Pangburn MK; Vogel CW; Fritzinger DC
Toxicon; 2020 Sep; 184():68-77. PubMed ID: 32526239
[TBL] [Abstract][Full Text] [Related]
6. New synthetic inhibitor to the alternative complement pathway.
Ikari N; Sakai Y; Hitomi Y; Fujii S
Immunology; 1983 Aug; 49(4):685-91. PubMed ID: 6553561
[TBL] [Abstract][Full Text] [Related]
7. Structure and function of recombinant cobra venom factor.
Kock MA; Hew BE; Bammert H; Fritzinger DC; Vogel CW
J Biol Chem; 2004 Jul; 279(29):30836-43. PubMed ID: 15131128
[TBL] [Abstract][Full Text] [Related]
8. Functional characterization of human C3/cobra venom factor hybrid proteins for therapeutic complement depletion.
Fritzinger DC; Hew BE; Thorne M; Pangburn MK; Janssen BJ; Gros P; Vogel CW
Dev Comp Immunol; 2009; 33(1):105-16. PubMed ID: 18760301
[TBL] [Abstract][Full Text] [Related]
9. Rosmarinic acid: a new inhibitor of complement C3-convertase with anti-inflammatory activity.
Englberger W; Hadding U; Etschenberg E; Graf E; Leyck S; Winkelmann J; Parnham MJ
Int J Immunopharmacol; 1988; 10(6):729-37. PubMed ID: 3198307
[TBL] [Abstract][Full Text] [Related]
10. Trypsin-activated complex of human factor B with cobra venom factor (CVF), cleaving C3 and C5 and generating a lytic factor for unsensitized guinea pig erythrocytes. I. Generation of the activated complex.
Miyama A; Kato T; Horai S; Yokoo J; Kashiba S
Biken J; 1975 Dec; 18(4):193-204. PubMed ID: 1218074
[TBL] [Abstract][Full Text] [Related]
11. A cobra venom factor (CVF)-induced C3 convertase activity in the hemolymph of Galleria mellonella.
Phipps D; Menger M; Chadwick JS; Aston WP
Dev Comp Immunol; 1987; 11(1):37-46. PubMed ID: 3647909
[TBL] [Abstract][Full Text] [Related]
12. Identification of functionally important amino acid sequences in cobra venom factor using human C3/Cobra venom factor hybrid proteins.
Hew BE; Fritzinger DC; Pangburn MK; Vogel CW
Toxicon; 2019 Sep; 167():106-116. PubMed ID: 31207349
[TBL] [Abstract][Full Text] [Related]
13. Ultrastructure of cobra venom factor-dependent C3/C5 convertase and its zymogen, factor B of human complement.
Smith CA; Vogel CW; Müller-Eberhard HJ
J Biol Chem; 1982 Sep; 257(17):9879-82. PubMed ID: 6921201
[TBL] [Abstract][Full Text] [Related]
14. Generation of anaphylatoxins through proteolytic processing of C3 and C5 by house dust mite protease.
Maruo K; Akaike T; Ono T; Okamoto T; Maeda H
J Allergy Clin Immunol; 1997 Aug; 100(2):253-60. PubMed ID: 9275149
[TBL] [Abstract][Full Text] [Related]
15. Effect of C3a and C5a anaphylatoxins on guinea-pig isolated blood vessels.
Marceau F; Hugli TE
J Pharmacol Exp Ther; 1984 Sep; 230(3):749-54. PubMed ID: 6332191
[TBL] [Abstract][Full Text] [Related]
16. Recombinant cobra venom factor.
Vogel CW; Fritzinger DC; Hew BE; Thorne M; Bammert H
Mol Immunol; 2004 Jun; 41(2-3):191-9. PubMed ID: 15159065
[TBL] [Abstract][Full Text] [Related]
17. The complement inhibitor FUT-175 suppresses T cell autoreactivity in experimental autoimmune encephalomyelitis.
Li Q; Nacion K; Bu H; Lin F
Am J Pathol; 2009 Aug; 175(2):661-7. PubMed ID: 19608865
[TBL] [Abstract][Full Text] [Related]
18. The crystal structure of cobra venom factor, a cofactor for C3- and C5-convertase CVFBb.
Krishnan V; Ponnuraj K; Xu Y; Macon K; Volanakis JE; Narayana SV
Structure; 2009 Apr; 17(4):611-9. PubMed ID: 19368894
[TBL] [Abstract][Full Text] [Related]
19. Functional role of the noncatalytic subunit of complement C5 convertase.
Rawal N; Pangburn MK
J Immunol; 2000 Feb; 164(3):1379-85. PubMed ID: 10640753
[TBL] [Abstract][Full Text] [Related]
20. Detection of native human complement components C3 and C5 and their primary activation peptides C3a and C5a (anaphylatoxic peptides) by ELISAs with monoclonal antibodies.
Klos A; Ihrig V; Messner M; Grabbe J; Bitter-Suermann D
J Immunol Methods; 1988 Jul; 111(2):241-52. PubMed ID: 3260926
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]